markets

Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?

Yahoo Finance

Pfizer’s Turnaround is Gaining Traction, but Can New Products Offset its Patent Cliff?

Yahoo Finance

Is Johnson & Johnson’s $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over?

Yahoo Finance

Diesel Crisis Threatens to Outlast the Middle East War

Yahoo Finance

Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside?

Yahoo Finance

Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?

Yahoo Finance

The next big oil trade may have nothing to do with oil stocks

Yahoo Finance

Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?

Yahoo Finance

Stock futures slip as U.S. and Canada appear headed for trade war

U.S. stock-index futures dipped on Sunday, as it appeared the U.S. was on the verge of an all-out trade war with Canada, one of its biggest trade partners.

MarketWatch

Danaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet?

Yahoo Finance

Thermo Fisher vs. Intuitive Surgical: Which Premium Healthcare Stock Deserves its Valuation?

Yahoo Finance

Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?

Yahoo Finance

Pemex and Petrobras Bet Big on High-Risk High-Reward Drilling Off Mexico

Yahoo Finance

If a Bear Market Is Coming, Here's What All of the Smartest Investors Are Doing Right Now

Yahoo Finance

Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?

Yahoo Finance

Billionaire Druckenmiller makes cancer stock his #1 buy for a reason

Yahoo Finance

After Buying Circle Through a 42% Drop, Cathie Wood Says Analysts Cannot Fathom It

Yahoo Finance

Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?

Yahoo Finance